eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
10.51
-0.34 (-3.13%)
Feb 6, 2026, 4:00 PM EST - Market closed
eXoZymes Employees
eXoZymes had 31 employees as of December 31, 2024. The number of employees increased by 2 or 6.90% compared to the previous year.
Employees
31
Change (1Y)
2
Growth (1Y)
6.90%
Revenue / Employee
n/a
Profits / Employee
-$269,022
Market Cap
88.29M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Precision BioSciences | 67 |
| aTyr Pharma | 65 |
| Pyxis Oncology | 44 |
| Biomea Fusion | 42 |
| Equillium | 35 |
| Cassava Sciences | 30 |
| Cognition Therapeutics | 28 |
EXOZ News
- 8 days ago - eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run - Accesswire
- 2 months ago - eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion - Accesswire
- 3 months ago - eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today - Accesswire
- 3 months ago - eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff - Accesswire
- 3 months ago - eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST - Accesswire
- 3 months ago - CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference - Accesswire
- 3 months ago - CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference - Accesswire
- 3 months ago - CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference - Accesswire